Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent

New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent

April 28, 2008

LONDON: Children who attend day care or play groups have about a 30% lower risk of developing the most common type of childhood leukaemia than those who do not, according to a new analysis of studies investigating the link.

The new research, to be presented Tuesday at the 2nd CHILDREN with LEUKAEMIA Causes and Prevention of Childhood Leukaemia Conference in London, is the first comprehensive analysis of studies investigating the association between social contact and childhood leukaemia.




"Combining the results from these studies together provided us with more confidence that the protective effect is real. Analysing the evidence in this way gives a more reliable answer to the question and a more precise estimate of the magnitude of the effect," said the study's leader, Dr. Patricia Buffler, professor of epidemiology at the School of Public Health of the University of California, Berkeley.

While the analysis does not reveal how intense social contact might ward off childhood leukaemia, it bolsters the theory that children exposed to common infections early in life gain protection from the disease. It is known that environments such as day care centres increase the chance of infections spreading. Some proponents of the theory believe that if the immune system is not challenged early in life and does not develop normally it may mount an inappropriate response to infections encountered later in childhood and that this could provoke the development of leukaemia.

Leukaemia is the most common cancer found in children in the industrialised world, affecting about one in 2,000 children. Incidence of the disease has been on the increase for decades. Acute lymphoblastic leukaemia, or ALL, the type of leukaemia the studies focused on, accounts for more than 80% of cases and most often occurs in children aged between 2 and 5 years. Scientists believe that for most types of childhood leukaemia to develop, there first must be a genetic mutation in the womb, followed by a second trigger during childhood that results in 1% of those children developing the disease. Infection - or the timing of infection - is one of the suspected triggers.

Buffler's analysis included 14 published studies comprising a total of 6,108 children with leukaemia and 13,704 without the disease. Parents were asked about day care and playgroup attendance, as well as other forms of social interaction with other children. The studies varied in the timing, duration and extent of social contact investigated and in the age groups and types of leukaemia studied. Twelve of the studies found some indication of a protective effect of social interaction with other children, while two found no effect. No study found that social contact increased the risk of childhood leukaemia.

"Our analysis concluded that children who attended day care or play groups had about a 30% lower risk of developing leukaemia than those who did not. Combined results for studies of day care attendance specifically before the age of 1 or 2 showed a similarly reduced risk," Buffler said.

The protective effect became even stronger when the researchers omitted from the analysis 5 studies in which the selection of healthy children for the comparison group relied on methods not considered optimal. In that analysis, children exposed to social contact were almost 40% less likely to go on to develop leukaemia than their counterparts.

In a separate report released at the conference on Tuesday by CHILDREN with LEUKAEMIA, scientists reviewed the evidence from studies that have investigated a link between infection and childhood leukaemia. They examined not only the idea that early life infections protect against the disease but also whether vaccination plays a role. In addition, they examined two other related areas of research: the role of infection during pregnancy and whether infection might be a factor influencing childhood leukaemia risk in situations where the population mix changes.

The report concluded that the evidence regarding whether infection during pregnancy or in situations of unusual patterns of population mixing influences the risk is inconclusive at present and that further research is necessary.

"On the question of whether infection early in life protects against leukaemia, the best evidence comes from studies of indirect measures of infection - which eliminates many of the problems common in trying to study infections directly - as well as from studies on immune system stimulation and on the genetics of immune responses," said one of the report's authors, Dr. Adrienne Morgan, staff scientist at CHILDREN with LEUKAEMIA.

"Putting our review together with the new analysis on social interaction, we can say pretty confidently that childcare, breastfeeding and vaccination are good things. This gives a steer to the biologists looking for what mechanisms might be at play," she said.

Children With Leukaemia



Related Leukaemia Current Events and Leukaemia News Articles Leukaemia Current Events and Leukaemia News RSS Leukaemia Current Events and Leukaemia News RSS
Paradoxical protein might prevent cancer
One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells. By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling colon cancer. The study is presented in the prestigious journal Cell.

New cancer gene discovered
A new cancer gene has been discovered by a research group at the Sahlgrenska Academy. The gene causes an insidious form of glandular cancer usually in the head and neck and in women also in the breast. The discovery could lead to quicker and better diagnosis and more effective treatment.

Master gene that switches on disease-fighting cells identified by scientists
The master gene that causes blood stem cells to turn into disease-fighting 'Natural Killer' (NK) immune cells has been identified by scientists, in a study published in Nature Immunology today.

Human sperm created from embryonic stem cells
Human sperm have been created using embryonic stem cells for the first time in a scientific development which will lead researchers to a better understanding of the causes of infertility.

Cancer survivors at greater risk of birth complications; special monitoring needed
Survivors of childhood cancer run particular risks when pregnant and should be closely monitored.

If plants could talk, what would they say?
If plants could speak they will boast about being part of remedies such as the common aspirin to a leukaemia drug derived from the rosy periwinkle.

New genes involved in Acute Lymphoblastic Leukemia play fundamental role in prognosis of the disease
The inactivity or "silence" of certain genes plays a fundamental role in the prognosis of acute lymphoblastic leukemia (ALL) as well as in response to treatment, according to the results of research involving a team made up of specialists from the University Hospital of Navarra and the Centre for Applied Medical Research (CIMA) at the same University of Navarra, as well as the Reina Sofía Hospital in Córdoba, Andalusia.

New treatment hope for prostate cancer
Scientists at Melbourne's Burnet Institute have developed a potential new treatment for patients with prostate cancer. An article, which described the invention, has recently been published in the prestigious international journal The Journal of Clinical Investigation.

New study aims to reduce risk of childhood leukemia
A study led by Dr Marcus Cooke at the University of Leicester and funded by World Cancer Research Fund (WCRF) UK is looking at whether consuming caffeine during pregnancy might affect the unborn baby's risk of developing leukaemia in childhood.

New hope for multiple sclerosis sufferers
A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).
More Leukaemia Current Events and Leukaemia News Articles
  Childhood Leukaemia: Prevention Its Cure? a Practical Guide
by Leonie Gough (Author)



Blwyddyn Nesa Efallai Leukaemia

Blwyddyn Nesa Efallai Leukaemia
Datblygu (Primary Contributor)



Leukaemia Diagnosis

Leukaemia Diagnosis
by Barbara J. Bain (Editor)

Imperial College, London, UK. Provides completely new and updated information on the molecular basis of leukemia using new WHO guidelines for diagnosis and classification. Provides a firm base in cytology and cytochemistry and includes the major advances in the fields of immunopheotyping, cytogenetics, and molecular genetics. Color illustrations. DNLM: Leukemia-classification.

The Restoring Extract (Xiao Jian Zhong Wan) 200 Pills X 12

The Restoring Extract (Xiao Jian Zhong Wan) 200 Pills X 12
by Lanzhou Traditional Herbs

The Restoring Extract (xiao jian zhong wan). Packing: 200 pills per bottle, 160 mg per pill. Manufactured by Lanzhou Traditional Herbs, China. A classical prescription originally appeared in Treatise on Febrile (Shang Han Lun), Xiao Jian Zhong Tang, translated as Minor Construct the Middle Decoction, commonly used by doctors in China for cases of deficiency-cold of middle energizer and disharmony of liver and spleen, such as stomach or duodenal ulcer, chronic hepatitis, and chronic stomach disorder.

Hairy-cell Leukaemia

Hairy-cell Leukaemia
by John Burthem (Author), John C. Cawley (Author)

University of Liverpool, U.K. Review of the current clinical research on hairy-cell leukaemia, for investigators and clinicians. Discusses differential diagnosis and curative treatments for the disorder. DNLM: Leukemia, Hairy Cell.

  Leukaemias, Lymphomas and Allied Disorders
by A.H. Goldstone (Author), etc. (Author)



The Famous Hat - This book has been designed to help children with leukaemia (or other forms of cancer) to prepare for treatment, namely chemotherapy, and a stay in hospital.

The Famous Hat - This book has been designed to help children with leukaemia (or other forms of cancer) to prepare for treatment, namely chemotherapy, and a stay in hospital.
by Kate Gaynor (Author), Liam Gaynor (Editor), Ruth Keating (Editor)

This book has been designed to help children with leukaemia (or other forms of cancer) to prepare for treatment, namely chemotherapy, and a stay in hospital. Treatment for childhood cancer can be very difficult to cope with, especially for very young children. The lengthy stay in hospital, having to contend with drips, tubes and injections is difficult enough without the possibility of hair loss for children to face. However, this book helps children to see the experience of a child that they can easily relate to. Harry not only enjoys his stay in hospital and makes new friends, but he also overcomes any fears of losing his hair. Most importantly, the book shows children that this experience is only temporary; it is not a permanent part of their lives. It assures them that there will be a...

White Blood: Personal Journeys With Childhood Leukaemia

White Blood: Personal Journeys With Childhood Leukaemia
by Mel Greaves (Author), Mel Greaves (Editor)

There are countless academic books on the subject of childhood leukemia. The idea behind this book, however, is very different. Here, we look at the extraordinary story of childhood leukemia from very distinct and unique perspectives: a distinguished physician who has lived through the transition of the disease from despair to success (and who played a key role in the latter); a distinguished laboratory scientist who has helped breach the barrenness of biological ignorance of the disease to reveal its nature; a patient who has been confronted with the tough realities of the illness and has been cured; and parents who have been given the worst possible news -- that their child is diagnosed with leukemia -- and who have endured the prolonged treatment, hope, and despair or relief...

  Leukaemia Diagnosis: A Guide to the Fab Classification
by Barbara J. Bain (Author)

Leukaemia is a complex group of diseases characterized by abnormal changes in any or several of the types of white blood cells. Because of the complexity of the various leukaemias, a systematic classification is essential to all involved in the study, analysis and assessment of the condition. This volume will be a comprehensive visual guide to the most important of the classifications to have evolved - the French-American_British (FAB) cooperative group classification. This system is used in Haematology departments throughout the world. But despite this widespread use, details of the system have yet to be contained in a single volume. Usually they form only a small section in Haematology atlases. This book contains important background information on use of cytogenetics, cytochemistry and...

  The Lymphoid Leukaemias
by Daniel Catovsky (Author), Robert Foa (Author)

Various topics on the subject of lymphoid leukaemias are covered in this book, including immunological markers, acute lymphoblastic leukaemia, B-cell chronic lymphocytic leukaemia and plasma cell neoplasms.

© 2009 BrightSurf.com